大(da)(da)健(jian)康國(guo)際集(ji)團(tuan)控(kong)股有限公司(si)(「大(da)(da)健(jian)康國(guo)際」或「公司(si)」,股份代(dai)號:[2211])是中(zhong)國(guo)東(dong)北(bei)(bei)地區(qu)領先(xian)的(de)(de)醫(yi)藥(yao)零(ling)(ling)售(shou)(shou)(shou)商(shang)(shang)(shang)及分銷商(shang)(shang)(shang)之(zhi)一。公司(si)擁有中(zhong)國(guo)東(dong)北(bei)(bei)地區(qu)較大(da)(da)的(de)(de)醫(yi)藥(yao)零(ling)(ling)售(shou)(shou)(shou)連鎖網(wang)絡并為(wei)(wei)中(zhong)國(guo)東(dong)北(bei)(bei)地區(qu)較大(da)(da)的(de)(de)民營(ying)(ying)醫(yi)藥(yao)分銷商(shang)(shang)(shang)。截至最后實際可行日期,公司(si)在(zai)(zai)中(zhong)國(guo)東(dong)北(bei)(bei)地區(qu)擁有953家零(ling)(ling)售(shou)(shou)(shou)藥(yao)店(dian)(dian)(dian),并在(zai)(zai)香港有四家零(ling)(ling)售(shou)(shou)(shou)藥(yao)店(dian)(dian)(dian),全部均為(wei)(wei)自營(ying)(ying)藥(yao)店(dian)(dian)(dian)。公司(si)擁有約(yue)6,500名分銷客戶。公司(si)擁有較高(gao)的(de)(de)凈利(li)(li)潤率,得益于側重品(pin)(pin)牌高(gao)毛利(li)(li)產(chan)品(pin)(pin)的(de)(de)產(chan)品(pin)(pin)組(zu)合、獨特的(de)(de)直供模式(shi)、集(ji)中(zhong)采(cai)購平臺(tai)和(he)低運(yun)(yun)營(ying)(ying)成(cheng)(cheng)本。公司(si)通過金天(tian)學院為(wei)(wei)員工和(he)客戶提供培訓課(ke)程,亦具(ju)備(bei)強大(da)(da)的(de)(de)收購與整(zheng)合執行力(li),將(jiang)產(chan)品(pin)(pin)組(zu)合、先(xian)進(jin)的(de)(de)業(ye)務模式(shi)及成(cheng)(cheng)熟(shu)的(de)(de)營(ying)(ying)運(yun)(yun)程序運(yun)(yun)用至被收購業(ye)務。公司(si)已形(xing)成(cheng)(cheng)獨特的(de)(de)商(shang)(shang)(shang)業(ye)模式(shi)和(he)核心(xin)競爭優勢,并致力(li)在(zai)(zai)藥(yao)品(pin)(pin)零(ling)(ling)售(shou)(shou)(shou)及分銷的(de)(de)專業(ye)基礎上(shang),充(chong)實更多健(jian)康類產(chan)品(pin)(pin)進(jin)入(ru)銷售(shou)(shou)(shou)管道,推行大(da)(da)健(jian)康行業(ye)理(li)念。